[go: up one dir, main page]

FR2776661B1 - IMMUNOREACTIVE POLYPEPTIDE OF THE NGF TRKA RECEPTOR AND USES - Google Patents

IMMUNOREACTIVE POLYPEPTIDE OF THE NGF TRKA RECEPTOR AND USES

Info

Publication number
FR2776661B1
FR2776661B1 FR9804011A FR9804011A FR2776661B1 FR 2776661 B1 FR2776661 B1 FR 2776661B1 FR 9804011 A FR9804011 A FR 9804011A FR 9804011 A FR9804011 A FR 9804011A FR 2776661 B1 FR2776661 B1 FR 2776661B1
Authority
FR
France
Prior art keywords
trka receptor
immunoreactive polypeptide
ngf trka
ngf
immunoreactive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9804011A
Other languages
French (fr)
Other versions
FR2776661A1 (en
Inventor
Brian Rudkin
Zanca Dionisio Martin
Gerard Ian Evan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR9804011A priority Critical patent/FR2776661B1/en
Priority to PCT/FR1999/000716 priority patent/WO1999048908A2/en
Publication of FR2776661A1 publication Critical patent/FR2776661A1/en
Application granted granted Critical
Publication of FR2776661B1 publication Critical patent/FR2776661B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/48—Nerve growth factor [NGF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR9804011A 1998-03-26 1998-03-26 IMMUNOREACTIVE POLYPEPTIDE OF THE NGF TRKA RECEPTOR AND USES Expired - Lifetime FR2776661B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR9804011A FR2776661B1 (en) 1998-03-26 1998-03-26 IMMUNOREACTIVE POLYPEPTIDE OF THE NGF TRKA RECEPTOR AND USES
PCT/FR1999/000716 WO1999048908A2 (en) 1998-03-26 1999-03-26 NGF TrkA RECEPTOR IMMUNOREACTIVE POLYPEPTIDE AND USES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9804011A FR2776661B1 (en) 1998-03-26 1998-03-26 IMMUNOREACTIVE POLYPEPTIDE OF THE NGF TRKA RECEPTOR AND USES

Publications (2)

Publication Number Publication Date
FR2776661A1 FR2776661A1 (en) 1999-10-01
FR2776661B1 true FR2776661B1 (en) 2002-04-05

Family

ID=9524717

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9804011A Expired - Lifetime FR2776661B1 (en) 1998-03-26 1998-03-26 IMMUNOREACTIVE POLYPEPTIDE OF THE NGF TRKA RECEPTOR AND USES

Country Status (2)

Country Link
FR (1) FR2776661B1 (en)
WO (1) WO1999048908A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9807781D0 (en) * 1998-04-09 1998-06-10 Univ Bristol Therapeutic agent
WO2004085648A2 (en) 2003-03-19 2004-10-07 Biogen Idec Ma Inc. Nogo receptor binding protein
BRPI0512500A (en) 2004-06-24 2008-03-11 Biogen Idec Inc treatment or conditions involving demyelination
RS53058B (en) 2005-07-08 2014-04-30 Biogen Idec Ma Inc. SP35 ANTIBODIES AND THEIR APPLICATIONS
EP2068866A4 (en) * 2006-07-24 2010-04-07 Biogen Idec Inc Methods for promoting myelination, neuronal survival and oligodendrocyte differentiation via administration of sp35 or trka antagonists
DK2982695T3 (en) 2008-07-09 2019-05-13 Biogen Ma Inc COMPOSITIONS CONCERNING ANTIBODIES AGAINST LINGO OR FRAGMENTS THEREOF
EP2849787A4 (en) 2012-05-14 2016-06-15 Biogen Ma Inc LINGO-2 ANTAGONISTS FOR THE TREATMENT OF DISORDERS INVOLVING ENGINE NEURONS
MX2017009038A (en) 2015-01-08 2017-10-25 Biogen Ma Inc Lingo-1 antagonists and uses for treatment of demyelinating disorders.
WO2024036890A1 (en) * 2022-08-19 2024-02-22 广东东阳光药业股份有限公司 Trka antigen epitope peptide and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69408541T2 (en) * 1993-11-23 1998-08-06 Genentech, Inc., South San Francisco, Calif. KINAS RECEPTOR ACTIVATION TEST
US5688911A (en) * 1995-05-03 1997-11-18 Schneider; Rainer Trk neurotrophin binding motifs
GB9525180D0 (en) * 1995-12-08 1996-02-07 Univ Mcgill Design of hormone-like antibodies with agonistic and antagonistic fuctions
GB9616105D0 (en) * 1996-07-31 1996-09-11 Univ Kingston TrkA binding site of NGF

Also Published As

Publication number Publication date
WO1999048908A2 (en) 1999-09-30
FR2776661A1 (en) 1999-10-01
WO1999048908A3 (en) 1999-12-16

Similar Documents

Publication Publication Date Title
DK0876482T3 (en) IL-13 receptor polypeptide
DE69622144D1 (en) General remote procedure call system and general remote procedure call procedure
DE69734443D1 (en) OB RECEPTOR AND LIGANDS
DE69636472D1 (en) DIVERSITY RECEIVER AND RELATED TAX PROCEDURE
NO983737D0 (en) IL-8 receptor antagonists
DE69825327D1 (en) Test arrangement and test procedure
DK0941994T3 (en) Pyrazolopyrimidines and pyrazolotriazines with 5-HT6 receptor affinity
NO20001100D0 (en) IL-8 receptor antagonists
NO990668L (en) IL-8 receptor antagonists
EP0880511A4 (en) INTEGRIN RECEPTOR ANTAGONISTS
ID19207A (en) TEXTILE WITH STRUCTURE OF IKAT WEAVING JOINT
FR2776661B1 (en) IMMUNOREACTIVE POLYPEPTIDE OF THE NGF TRKA RECEPTOR AND USES
EP1015473A4 (en) CLONING AND EXPRESSION OF BETA-APP-C100 RECEPTOR (C100-R)
DE69709808D1 (en) Electrophotographic support and electrophotographic developer
DE69838874D1 (en) IL-8 RECEPTOR ANTAGONISTS
ATE303370T1 (en) IL-8 RECEPTOR ANTAGONISTS
DE69824837D1 (en) IL-8 RECEPTOR ANTAGONISTS
DE69635060D1 (en) PROCESSOR WITH EMBEDDED IN-CIRCUIT PROGRAMMING STRUCTURES
FR2771741B1 (en) SPLICE VARIANTS OF THE HUMAN 5-HT4 SEROTONINERGIC RECEPTOR AND THEIR APPLICATIONS, ESPECIALLY FOR SCREENING
EP0781133A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
FI2336U1 (en) Joint structure of building elements
EP1004665A4 (en) PROTEINS OF THE ACCEPTOR RECEPTOR TYPE
ID19821A (en) PARTITION AND INSTALLATION STRUCTURE
ID18272A (en) INSTALLATION OF GENERAL PHONE AND COVERAGE STRUCTURE
ID19881A (en) STRUCTURE OF BUILDING ELEMENTS

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20